PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 52.90
-1.70 (-3.11%)
Nov 6, 2026, 1:30 PM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 7.6 billion as of November 6, 2026. It is the 19,495th most valuable company in the world and the 786th biggest in Taiwan. Its market cap has decreased by 25.91% in one year.
Market Cap
7.60B
Enterprise Value
2.57B
Revenue
1.03B
Global Rank
Country Rank
#786 Taiwan
PE Ratio
14.11
ChartMarket Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 7.60B, an increase of 41.31%. That is a compound annual growth rate of 2.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 7.60B | -24.86% |
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 8.27B |
| Locus Cell | 7.45B |
| Tanvex BioPharma | 7.13B |
| Acepodia | 7.06B |
| Adimmune | 7.00B |
| Polaris Group | 6.65B |
| Savior Lifetec | 6.27B |
| OBI Pharma | 6.18B |